NEW YORK – The US Fsood and Drug Administration today approved a new combination treatment from Genentech for HER2-positive metastatic breast cancer that may be administered to patients in their homes by a qualified healthcare professional.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.